Position in LH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,669,640
-$45,414 QoQ
Shares Held
5,963
-7.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#391
of 1,047 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Allworth Financial LP holds $27,679,675 across 34 Diagnostics & Research names. LH ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,334 | $12,200,093 | |
| 2 | A |
Agilent Technologies, Inc.
|
20,420 | $2,712,388 | |
| 3 | DHR |
Danaher Corp /De/
|
11,176 | $2,128,804 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
3,894 | $2,062,223 | |
| 5 | LH |
Labcorp Holdings Inc.
This page
|
5,963 | $1,669,640 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
2,531 | $1,332,419 | |
| 7 | NTRA |
Natera, Inc.
|
3,878 | $1,052,683 | |
| 8 | ILMN |
Illumina, Inc.
|
5,976 | $1,050,760 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,669,640 | 5,963 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,715,054 | 6,428 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,622,440 | 6,467 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,658,919 | 5,779 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $1,478,193 | 5,631 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $148,488 | 638 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $144,700 | 631 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $98,554 | 441 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $89,951 | 442 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||